Sansure Biotech Inc.

SHSE:688289 Stock Report

Market Cap: CN¥13.9b

Sansure Biotech Management

Management criteria checks 3/4

Sansure Biotech's CEO is Lizhong Dai, appointed in Jul 2019, has a tenure of 5.33 years. directly owns 33.21% of the company’s shares, worth CN¥4.63B. The average tenure of the management team and the board of directors is 5.3 years and 5.3 years respectively.

Key information

Lizhong Dai

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure5.3yrs
CEO ownership33.2%
Management average tenure5.3yrs
Board average tenure5.3yrs

Recent management updates

Recent updates

Sansure Biotech's (SHSE:688289) Problems Go Beyond Weak Profit

Nov 03
Sansure Biotech's (SHSE:688289) Problems Go Beyond Weak Profit

Sansure Biotech Inc.'s (SHSE:688289) 39% Price Boost Is Out Of Tune With Earnings

Oct 09
Sansure Biotech Inc.'s (SHSE:688289) 39% Price Boost Is Out Of Tune With Earnings

Sansure Biotech (SHSE:688289) Could Be Struggling To Allocate Capital

Oct 03
Sansure Biotech (SHSE:688289) Could Be Struggling To Allocate Capital

Is Sansure Biotech (SHSE:688289) A Risky Investment?

Sep 12
Is Sansure Biotech (SHSE:688289) A Risky Investment?

Sansure Biotech Inc. (SHSE:688289) Investors Are Less Pessimistic Than Expected

Aug 21
Sansure Biotech Inc. (SHSE:688289) Investors Are Less Pessimistic Than Expected

Sansure Biotech (SHSE:688289) May Have Issues Allocating Its Capital

Jun 03
Sansure Biotech (SHSE:688289) May Have Issues Allocating Its Capital

Why Sansure Biotech's (SHSE:688289) Soft Earnings Are Just The Beginning Of Its Problems

May 03
Why Sansure Biotech's (SHSE:688289) Soft Earnings Are Just The Beginning Of Its Problems

Sansure Biotech Inc.'s (SHSE:688289) Business Is Trailing The Industry But Its Shares Aren't

Apr 26
Sansure Biotech Inc.'s (SHSE:688289) Business Is Trailing The Industry But Its Shares Aren't

Sansure Biotech's (SHSE:688289) Returns On Capital Are Heading Higher

Feb 28
Sansure Biotech's (SHSE:688289) Returns On Capital Are Heading Higher

CEO

Lizhong Dai (56 yo)

5.3yrs

Tenure

CN¥991,000

Compensation

Mr. Lizhong Dai is Chairman of the Board and General Manager of Sansure Biotech Inc. from July 2019.


Leadership Team

NamePositionTenureCompensationOwnership
Lizhong Dai
Chairman of the Board & GM5.3yrsCN¥991.00k33.21%
CN¥ 4.6b
Peng Zhu
CFO, Deputy GM5.3yrsCN¥1.14m0.067%
CN¥ 9.3m
Xialin Yu
Deputy GM & Director5.3yrsCN¥675.40k0.026%
CN¥ 3.7m
Xu Fan
Deputy GM & Director5.3yrsCN¥1.07m0.054%
CN¥ 7.5m
Jia Liu
Deputy GM & Directorno dataCN¥1.03m0.035%
CN¥ 4.9m
Zhongping Deng
Deputy General Manager5.8yrsCN¥973.70k0.019%
CN¥ 2.6m
Jun Zhou
Deputy General Manager5.3yrsCN¥1.11m0.016%
CN¥ 2.2m
Liu Kai
Deputy General Manager3.3yrsCN¥1.90m0.026%
CN¥ 3.6m
Jian Zhu
Deputy General Manager3.3yrsCN¥3.05m0.025%
CN¥ 3.4m
Haixiao Wang
Deputy General Manager2.3yrsCN¥2.15m0.041%
CN¥ 5.7m
Xiaoyan Xiong
Deputy General Manager2.1yrsCN¥868.70k0.022%
CN¥ 3.1m

5.3yrs

Average Tenure

47yo

Average Age

Experienced Management: 688289's management team is seasoned and experienced (5.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Lizhong Dai
Chairman of the Board & GM5.3yrsCN¥991.00k33.21%
CN¥ 4.6b
Peng Zhu
CFO, Deputy GM4.8yrsCN¥1.14m0.067%
CN¥ 9.3m
Xialin Yu
Deputy GM & Director5.3yrsCN¥675.40k0.026%
CN¥ 3.7m
Xu Fan
Deputy GM & Director4.1yrsCN¥1.07m0.054%
CN¥ 7.5m
Jia Liu
Deputy GM & Director2.3yrsCN¥1.03m0.035%
CN¥ 4.9m
Wu Tan
Chairman of Supervisory Board5.3yrsno data0.035%
CN¥ 4.9m
Ya Cao
Independent Director5.3yrsCN¥75.00kno data
Yuan Fang
Director5.3yrsno datano data
Ling Lin
Supervisor2.3yrsno data0.00040%
CN¥ 55.7k

5.3yrs

Average Tenure

45yo

Average Age

Experienced Board: 688289's board of directors are considered experienced (5.3 years average tenure).